A randomized, double-blind, placebo - controlled study of safety of the adjunctive saffron on sexual dysfunction induced by a selective serotonin reuptake inhibitor

Journal of Medicinal Plants

Volumn 10, Issue 37, 2011, Pages 121-130

  Mansoori, P ^a   Akhondzadeh, S ^a   Raisi, F ^a   Ghaeli, P ^a   Jamshidi, A H ^b   Nasehi, A A ^a   Sohrabi, H ^a   Saroukhani, S ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b AVICENNA RESEARCH INSTITUTE   (Iran)

Author keywords

Adverse effects; Crocus sativus; MDD; Saffron; SSRI

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; CREATININE; CROCUS SATIVUS EXTRACT; GLUCOSE; HEMOGLOBIN; PLACEBO; SEROTONIN UPTAKE INHIBITOR; TRIACYLGLYCEROL;

ABDOMINAL PAIN; ADD ON THERAPY; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANXIETY DISORDER; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONSTIPATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CROCUS; DIZZINESS; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG CAPSULE; DRUG SAFETY; ERYTHROCYTE COUNT; GASTROESOPHAGEAL REFLUX; GLUCOSE BLOOD LEVEL; HEADACHE; HEMOGLOBIN BLOOD LEVEL; HUMAN; INTERNATIONAL NORMALIZED RATIO; LABORATORY TEST; LEUKOCYTE COUNT; MAJOR DEPRESSION; MALE; NAUSEA; OUTPATIENT; PROTHROMBIN TIME; RANDOMIZED CONTROLLED TRIAL; RESTLESSNESS; SEXUAL DYSFUNCTION; SIDE EFFECT; TACHYCARDIA; THROMBOCYTE COUNT; TREATMENT DURATION; UREA NITROGEN BLOOD LEVEL; XEROSTOMIA;

CROCUS SATIVUS;

EID: 79960622094     PISSN: 2717204X     EISSN: 27172058     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Schmidt M, Berti G, Hensel A. Saffron in phytotherapy: pharmacology and clinical uses. Wien Med Wochenschr. 2007; 157 (13-14): 315-9. (Pubitemid 47356256)
2. Ríos JL, Recio MC, Giner RM, Mariez S. An update review of saffron and its active constituents. Phytother Res. 1996; 10: 189-93.
3. Hosseinzadeh H, Khosravan V. Anticonvulsant effects of aqueous and ethanolic extracts of Crocus sativus L. stigmas in mice. Arch Iran Med. 2002; 5: 44-7. (Pubitemid 34591502)
4. Hosseinzadeh H,Sadeghnia HR. Protective effect of safranal on pentylenetetrazol-induced seizures in the rat: involvement of GABAergic and opioids systems. Phytomedicine 2007; 14 (4): 256-62.
5. Nam KN, Park YM, Jung HJ, Lee JY, Min BD, Park SU, Jung WS, Cho KH, Park JH, Kang I, Hong JW,Lee EH. Anti-inflammatory effects of crocin and crocetin in rat brain microglial cells. Eur. J. Pharmacol. 2010; 648: 110-6.
6. Basheeruddin Asdaq SM, Naseeruddin Inamdar M. Potential of Crocus sativus (saffron) and its constituent, crocin, as hypolipidemic and antioxidant in rats. Appl Biochem. Biotechnol. 2010; 162: 358-72.
7. Chryssanthi DG, Dedes PG, Karamanos NK, Cordopatis P, Lamari FN. Crocetin inhibits invasiveness of MDA-MB231 breast cancer cells via downregulation of matrix metalloproteinases. Planta Med. 2011; 77 (2): 146-51.
8. Pintado C, De Miguel A, Acevedo O, Nozal L, Novella JL, Rotger R. Bactericidal effect of saffron (Crocus sativus) on Salmonella enterica during storage. J. Foodcont. 2011; 22 (3-4): 638-42.
9. Hosseinzadeh H, Ghenaati G. Evaluation of the antitussive effect of stigma and petals of saffron (Crocus sativus) and its components, safranal and crocin in guinea pigs. Fitoterapia 2006; 77: 446-8. (Pubitemid 44308375)
10. Sarris J. Herbal medicine in the treatment of psychiatric disorders: a systematic review. Phytother Res. 2007; 21: 703-16. (Pubitemid 47217768)
11. Noorbala AA, Akhondzadeh S, Tahmacebi-Pour N, Jamshidi AH. Hydroalcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: a double-blind, randomized pilot trial. J. Ethnopharmacol. 2005; 97: 281-4. (Pubitemid 40222030)
12. Akhondzadeh S, Fallah-Pour H, Afkham kh, Jamshidi AH., Khalighi-Cigaroudi F. Comparison of Crocus sativus L. and Imipramine in the treatment of mild to moderate depression: A pilot double-blind randomized trial. BMC Complement Altern Med. 2004; 4: 12-7.
13. Agha-Hosseini M, Kashani L, Aleyaseen A, Ghoreishi A, Rahmanpour H, Zarrinara AR, Akhondzadeh S. Crocus sativus L. (saffron) in the treatment of premenstrual syndrome: a double-blind randomised and placebo-controlled trial. Br. J. Obstet. Gynaecol. 2008; 115 (4): 515-9.
14. Akhondzadeh S, Shafiee-Sabet M, Harirchian MH, Togha M, Cheraghmakani H, Razeghi S, Hejazi S.Sh, Yousefi MH, Alimardani R, Jamshidi A, Zare F, Moradi A. Saffron in the treatment of patients with mild to moderate Alzheimer's disease: a 16-week, randomized and placebo-controlled trial. J. Clin. Pharm. Ther. 2010; 35: 581-8.
15. Akhondzadeh S, Shafiee-Sabet M, Harirchian MH, Togha M, Cheraghmakani H, Razeghi S, Hejazi S.Sh, Alimardani R, Jamshidi A, Zare F,Moradi A. A 22-week multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer's disease. Psychopharmacol. 2010; 207: 637-43.
16. nd ed: 472-73.
17. Modaghegh MH, Shahabian M, Esmaeili HA, Rajbai O, Hosseinzadeh H. Safety evaluation of saffron (Crocus sativus) tablets in healthy volunteers. Phytomedicine 2008; 15: 1032-7.
18. Karimi G, Taiebi N, Hosseinzadeh A, Shirzad F. Evaluation of subacute toxicity of aqueous extract of Crocus sativus L. stigma and petal in rats. J. Med Plants 2004; 3: 29-35.
19. Üstün TB. The global burden of mental disorders. Am. J. Public Health 1999; 89 (9): 1315-18.
20. Akhondzadeh S, Maleki J. Herbal medicines in the treatment of psychiatric and neurologic disorders. Iran J. Psychiatry 2006; 1: 1-11.
21. Jorme A.F. Public knowledge and beliefs about mental disorders. Br. J. Psychiatry 2000; 177: 396-401.
22. Dubovsky SL. Beyond the serotonin reuptake inhibitors: rationales for the development of new serotonergic agents. J. Clin. Psychiatry 1994; 55: 34-44. (Pubitemid 24081835)
23. Patel V, Chisholm D, Rabe-Hesketh S, Dias-Saxena F, Andrew G, Mann A. Efficacy and cost-effectiveness of drug and psychological treatments for common mental disorders in general health care in Goa, India: a randomised, controlled trial. Lancet. 2003; 361 (9351): 33-9. (Pubitemid 36050959)
24. Ma Sh, Liu B, Zhou S, Xuxiang W, Yang Q, Zhou J. Pharmacological studies of glycosides of saffron (Crocus sativus): effects on blood coagulation, platelet aggregation, and thrombosis. Chin. Trad. Herbal Drugs 1999; 30: 196-8.
25. Okano K, Nishio T, Fukaya C, Yokoyama K, Nishimoto T, Matusmoto K. Isolation and identification of a platelet aggregation inhibitor from saffron (Crocus sativus Linne, Iridaceae). Wakan Iyaku Gakkaishi. 1992; 9: 175-81.
26. Shati AA, Alamri SA. Role of saffron (Crocus sativus L.) and honey syrup on aluminum-induced hepatotoxicity. Saudi Med J. 2010; 31 (10): 1106-13.
27. Routledge PA, O'Mahony MS, Woodhouse KW. Adverse drug reactions in elderly patients. Br. J. Clin. Pharmacol. 2004; 57(2): 121-6.
28. Halperin D, Rober G. Influence of antidepressants on hemostasis. Dialogues Clin. Neurosci. 2007; 9 (1): 47-59.
29. Hosseinzadeh H, Karimi G, Niapoor M. Anti-depressant effects of Crocus sativus stigma extracts and its constituents, crocin and safranal, in mice. Acta Hortic. 2004; 650: 435-45.
30. Karimi G, Hosseinzadeh H, Khalegh Panah P. Study of antidepressant effect of aqueous and ethanolic extract of crocus sativus in mice. Iranian J. Basic Med. Sci. 2001; 4 3 (11): 11-5.
31. Hosseinzadeh H, Ziaee T, Sadeghi A. The effect of saffron, Crocus sativus stigma, extract and its constituents, safranal and crocin on sexual behavior in normal male rats. Phytomedicine 2008; 15: 491-5. (Pubitemid 351783383)
32. Shamsa A, Hosseinzadeh H, Molaei M, Shekeri MT, Rajabi O. Evaluation of Crocus sativus L. (saffron) on male erectile dysfunction: a pilot study. Phytomedicine 2009; 16: 690-3.
33. Montejo AL, Llorca G, Izquierdo JA, Rico-Villademoros F. Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. J. Clin. Psychiatry 2001; 62 (supp 3): 10-21. (Pubitemid 32164676)
34. Akhondzadeh Basti A, Moshiri E, Noorbala AA, Jamshidi AH, Abbasi SH, Akhondzadeh S. Comparison of petal of Crocus sativus L. and fluoxetine in the treatment of depressed outpatients: a pilot double-blind randomized trial. Prog Neuropsychopharmacol. Biol. Psychiatry 2007; 31: 439-42.
35. Moshiri E, Basti AA, Noorbala AA, Jamshidi AH, Hesameddin Abbasi S, Akhondzadeh S. Crocus sativus L. (petal) in the treatment of mild-to-moderate depression: a double-blind, randomized and placebo-controlled trial. Phytomedicine 2006; 13: 607-11.
36. Akhondzadeh S, Jafari S, Raisi F, Nasehi AA, Ghoreishi A, Salehi B, Mohebbi-Rasa S, Raznahan M, Kamalipour A. Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial. Depress. Anxiety 2009; 26: 607-11.